Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesBeyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09
Leask SJ et al. – A data–driven subgroup of schizophrenia patients, characterized as lacking co–morbid depressive symptoms, is less heterogeneous with respect to neurodevelopmental etiology.
Related Articles
Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09
Relevance Score: 93%
Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09
Relevance Score: 92%
Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09
Relevance Score: 91%
Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09
Relevance Score: 91%
The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample
Schizophrenia Research, 10/09/09
Relevance Score: 91%
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms
Journal of General Internal Medicine, 12/07/09
Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients
Journal of General Internal Medicine, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor